Ahmadi P, Ghandili S, Jakobs F, Konnopka C, et al. Cost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective. Bone Marrow Transplant 2024 Feb 6. doi: 10.1038/s41409-024-02228.
PMID: 38321270